|
|
|
Volumn 37, Issue SUPPL. 3, 2002, Pages 13-15
|
|
Overview of the fluoroquinolones: Focus on moxifloxacin
a
a
201 202 LCI
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 AMINOBUTYRIC ACID A RECEPTOR;
ANTIBIOTIC AGENT;
CAFFEINE;
CINOXACIN;
CIPROFLOXACIN;
CLINAFLOXACIN;
ENOXACIN;
FLEROXACIN;
FLUMEQUINE;
GATIFLOXACIN;
GEMIFLOXACIN;
GREPAFLOXACIN;
LEVOFLOXACIN;
LOMEFLOXACIN;
MOXIFLOXACIN;
NALIDIXIC ACID;
NORFLOXACIN;
OFLOXACIN;
OXOLINIC ACID;
PAZUFLOXACIN;
PIPEMIDIC ACID;
PIROMIDIC ACID;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
RUFLOXACIN;
SITAFLOXACIN;
SPARFLOXACIN;
THEOPHYLLINE;
TOSUFLOXACIN;
TROVAFLOXACIN;
UNINDEXED DRUG;
ANAEROBIC BACTERIUM;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC THERAPY;
BACTERIAL INFECTION;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG INDICATION;
DRUG SAFETY;
DRUG STRUCTURE;
GRAM NEGATIVE BACTERIUM;
GRAM POSITIVE BACTERIUM;
HUMAN;
NONHUMAN;
PHOTOTOXICITY;
RESPIRATORY TRACT INFECTION;
SHORT SURVEY;
SIDE EFFECT;
SKIN INFECTION;
STRUCTURE ACTIVITY RELATION;
|
|
EID: 0036279219
PISSN: 1082801X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (5)
|
|
References (8)
|
